Saturday, January 28, 2023

#Biotech Review $XBI

Biotech Review
Trading noise, the random movement of price over the short term, does not control trends, cycles, and profits. The majority, an emotionally driven group focused solely on price, often interprets it as meaningful information. This leads to confusion, frustration, missed opportunities, and leaves the majority as the bag holders of trend transitions. The Evolution of the Trade helps investors stand separate from the majority.

The Biotechnology's overall trend, revealed by trends of price, leverage, and time, are defined in The Matrix for subscribers.

Subscriber Comments

The Nasdaq 100 Report, a series of videos, extends the discussion.

Biotechnology ($XBI), a leadership group in the technology laden indices like the NASDAQ, went from hero to zero from 2020 to 2022. Every die-hard biotech supporter has been fried like an egg on hot Georgia asphalt. As a result, the bulls have renounced this group as a POS (piece of shit).

Emotions, however, does not corrupt the Evolution of the Trade. The invisible hand does not speak, or hold conference calls for investors. Preparation comes through following the money. The computer tracks $XBI with the intensity of a highly trained assassin waiting for opportunity in deep cover.

Use your Subscription Level Access Code to access the full review.

Follow me on Twitter or Facebook for further discussion.


Market-driven money flow, trend, and intermarket analysis is provided by an Access Key.